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The antiparasitic effect of a collection of compounds with antimitotic activity has been tested on a mam-
malian cell line infected with Encephalitozoon intestinalis, a microsporidian causing intestinal and systemic
infection in immunocompromised patients. The antiparasitic effect was evaluated by counting the number of
parasitophorous vacuoles detected by immunofluorescence. Out of 526 compounds tested, 2 (pancratistatin
and 7-deoxynarciclasine) inhibited the infection without affecting the host cell. The 50% inhibitory concentra-
tions (IC50s) of pancratistatin and 7-deoxynarciclasine for E. intestinalis were 0.18 M and 0.2 M, respec-
tively, approximately eightfold lower than the IC50s of these same compounds against the host cells. Electron
microscopy confirmed the gradual decrease in the number of parasitophorous vacuoles and showed that of the
two life cycle phases, sporogony was more sensitive to the inhibitors than merogony. Furthermore, the per-
sistence of meronts in some cells apparently devoid of sporonts and spores indicated that the inhibitors block
development rather than entry of the parasite into the host cell. The occurrence of binucleate sporoblasts and
spores suggests that these inhibitors blocked a specific phase of cell division.
Microsporidia are widespread obligatory intracellular para-
sites, apparently able to invade any cell in animals and humans
(4, 16). These unicellular parasites have been increasingly rec-
ognized as opportunistic pathogens of immunodeficient pa-
tients (24). Two species cause diarrhea, malabsorption, and
weight loss in AIDS patients (6). Enterocytozoon bieneusi is the
most prevalent cause of these symptoms and is occasionally
associated with hepatobiliary disease or infection of the upper
respiratory tract (24). The second prevalent species, Encepha-
litozoon (Septata) intestinalis, is responsible for nephritis, bron-
chitis, and lytic mandibular lesions (11, 16). Rational strategies
for the development of chemotherapeutic agents against mi-
crosporidia require a better understanding of the mechanisms
controlling the proliferation of these parasites.
The life cycle of Encephalitozoon intestinalis (Fig. 1) consists
of two successive developmental sequences, merogony and
sporogony, both of which occur in a parasitophorous vacuole
(PV) within host cells. During merogony, proliferative stages
known as meronts are produced. After multiple divisions, mer-
onts are transformed into sporonts. During sporogony, each
sporont divides into two sporoblasts, which mature into spores
which are approximately 2.0 by 1.2 m. They contain a com-
plex extrusion apparatus which ensures inoculation of the in-
fective sporoplasm into a host cell. Meronts and sporonts are
mononucleate cells which replicate by binary fission. Some-
times, the karyokinetic process is repeated before cytokinesis
occurs, resulting in a ribbon-like cell containing two to four
nuclei. The production of tetranucleate meronts and sporonts
suggests some variability in the timing of cytokinetic cycles in
E. intestinalis (3). Sporoblasts and spores are exclusively mono-
nucleate, an indication that the regulation of development
must be linked to the control of the cell cycle. Although very
little is known about cell cycle control in microsporidia, a gene
encoding a putative homologue of the cyclin-dependent kinase
1 (CDK1) has been recently identified in Encephalitozoon cu-
niculi (20), and a similar gene from E. intestinalis is being
characterized in our laboratory (unpublished data). CDKs are
major players in the progression of the eukaryotic cell cycle.
Their activity is regulated by their phosphorylation status and
by the association with negative (cyclin kinase inhibitors) or
positive (cyclins) regulators, and by intracellular transloca-
tions. The temporary association of kinase subunits with dif-
ferent cyclins define time windows during which kinase activity
is directed at distinct sets of substrates at the appropriate
phase of the cell cycle.
Because of the importance of CDKs and their regulators in
the multiplication and development of eukaryotes, these en-
zymes represent attractive potential targets for antiparasitic
chemotherapy. The phylogenetic divergence between the par-
asite and its host is likely to result in divergences in the struc-
ture of their regulatory genes, as has been shown in other
parasite-host systems (9, 10, 15); such divergences might confer
to parasite and host differential susceptibilities to a given in-
hibitor. Therefore, we decided to evaluate the effect of a col-
lection of antimitotic compounds (many but not all of which
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are CDK inhibitors) on the course of cellular infection by E.
intestinalis.
MATERIALS AND METHODS
Inhibitors. Pancratistatin and 7-deoxynarciclasine were extracted and purified
from Pancratium (Hymenocallis) littorale in Hawaii (17).
Parasites. E. intestinalis spores were collected from monolayers of rabbit
kidney cells (RK13) as described by Van Gool et al. (22). Spores were harvested
every 3 days, and suspensions of parasites were centrifuged at 350  g for 5 min
to eliminate cellular fragments. Spores were then pelleted by centrifugation at
2,000  g for 20 min and washed twice. Spores were counted with a Malassez
slide and used immediately for infection of cultured cells.
Culturing of parasites and treatment. RK13 culture cells were cultivated in
Lab-Tek slides, in RPMI 1640 medium (Gibco BRL, Cergy Potoise, France)
supplemented with 8% heat-inactivated fetal calf serum (56°C for 30 min) (Sig-
ma, St. Quentin-Fallavier, France), streptomycin (100 g/ml), penicillin (100
U/ml) and L-glutamine (2 mM). Cells were adjusted to 105 cells/well and spores
from E. intestinalis were added to cultured cells at a ratio of 1 spore/10 cells. The
compounds were added to cultured cells at infection time. The effects of the
compounds were determined by counting the PVs 48 h after infection and
treatment. The detection of PVs was performed by immunofluorescence assay
(IFA).
IFA. The Lab-Tek slides were fixed in ethanol at 20°C for 10 min and then
incubated for 1 h at 37°C with the monoclonal antibody (MAb) M1.6C1.2C11 (1)
at a dilution of 1/500. This MAb is directed against a coat protein of sporogonic
FIG. 1. Life cycle of E. intestinalis. Only the spores survive in the
extracellular medium. The inoculation of the sporoplasm into the host
cell is the initial step of the intracellular development.
FIG. 2. Structures of pancratistatin and 7-deoxynarciclasine.
FIG. 3. (a) In vitro effect of inhibitors on E. intestinalis multi-
plication. RK13 cells infected with E. intestinalis spores were incu-
bated for 48 h, in the presence of various concentrations of inhib-
itors. The number of PVs was determined by IFA. The data
represent means  standard deviations (error bars) of triplicate
cultures. , significant difference between the PV number obtained
in treated culture and nontreated culture, as determined by Stu-
dent’s test (P  0.05). (b) In vitro effect of inhibitors on host cells
(RK13). Microculture plates prepared with RK13 cells were treated
with six concentrations of inhibitors. One microcurie of [3H]thymi-
dine (5 Ci/mmol) was added to each well. Plates were incubated for
48 h, and [3H]thymidine incorporation was measured. The data
represent means  standard deviations (error bars) of triplicate
cultures. , significant difference between the 3H incorporation by
the treated culture and nontreated culture, as determined by Stu-
dent’s test (P  0.05).
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stages generated in the PVs. The slides were then washed in phosphate-buffered
saline (PBS) and incubated with fluorescein-conjugated anti-mouse immuno-
globulin G, diluted to 1/100 in Evans blue (1/1,000). After several washes with
PBS, the slides were mounted in PBS-glycerol (50:50, vol/vol), and PVs were
counted using an epifluorescence microscope. The entire surface of each well
was examined at a magnification of 500.
Determination of IC50s on parasite. The concentration of inhibitor required to
inhibit parasite growth by 50% (IC50) was determined by IFA. The data were
plotted and the IC50s were determined using Cricket Graph software.
Determination of IC50s on host cells. Microculture plates (96-well flat-bottom
plates; Falcon) were prepared with RK13 cells. Six concentrations of each in-
hibitor were tested in triplicate. One microcurie of [3H] thymidine (5 Ci/mmol)
was added to each well. Plates were incubated for 48 h and [3H]thymidine
incorporation was measured with a scintillation counter (Beckman). The data
were plotted and the IC50s were determined using Cricket Graph software.
Electron microscopy. The effect of inhibitors on the morphology of E. intes-
tinalis and RK13 cells was examined by electron microscopy. Infected monolay-
ers were fixed at 48 h postinfection in 2.5% glutaraldehyde in 0.1 M Na caco-
dylate buffer (pH 7.2) for 1 h. They were rinsed in the same buffer and postfixed
in ferriosmium [OsO4 and K3Fe(CN)6 (1%, wt/vol) in cacodylate buffer] for 1 h
at room temperature. After ethanolic dehydration, the samples were embedded
in Spurr’s resin. Thin sections were stained with uranyl acetate and lead citrate
and then examined with a JEOL TEM 100CX transmission electron microscope.
RESULTS
Effect of inhibitors on parasite growth. RK13 cells infected
with E. intestinalis spores were incubated for 48 h in the pres-
ence of various concentrations of compounds. Since the stocks
of inhibitors were dissolved in dimethyl sulfoxide (DMSO),
controls were run simultaneously with the highest concentra-
tion of DMSO (0.03 l/ml) without inhibitor. The effect of the
inhibitors on parasite multiplication was evaluated from the
number of PVs detected by IFA. Microsporidia are fast-grow-
ing organisms, and 48 h postinfection, PVs were detectable by
IFA due to the occurrence of sporogonic stages cross-reacting
with the MAb.
In the first round of screening, 526 compounds were tested
at concentrations of 2 and 5 M. As expected, most com-
pounds were toxic to the host cells and caused cytopathic
effects. The 51 compounds that showed little or no cytopathic
effect on the host cells were tested again at a concentration
range of 0.1 to 5 M for antiparasitic effect. This allowed us to
select two structurally related molecules with a definite effect
on the number of PVs but with no apparent effect on the host
cells: pancratistatin and 7-deoxynarciclasine (Fig. 2). IC50s of
pancratistatin and 7-deoxynarciclasine, determined using a
range of concentrations between 0.01 and 3 M (Fig. 3a),
were, respectively, 0.18 and 0.2 M. No parasite growth could
be detected at the highest pancratistatin concentration (3 M).
Low concentrations of this inhibitor (0.01 M) also signifi-
cantly reduced the parasite development. Likewise, in infected
cultures treated with 7-deoxynarciclasine, the number of par-
asites decreased markedly at higher concentrations. Thus, pan-
cratistatin and 7-deoxynarciclasine showed very good antipar-
asitic activity.
Host cell IC50s. To determine whether any of these two
molecules may represent a useful lead compound, we next
measured their effect on host cells in a standard [3H]thymidine
incorporation assay. RK13 cells were treated with the two
inhibitors (concentrations ranging from 0.01 to 10 M), and
incorporated radiolabel was then measured (see Materials and
Methods). Again, cells treated with DMSO diluted in RPMI
and RPMI alone were used as controls. The IC50s of pancra-
tistatin and 7-deoxynarciclasine obtained from the graphs (Fig.
3b) were both 1.5 M and thus were 8- and 7.5-fold higher
than the parasite IC50s, respectively.
Morphological effects of the inhibitors. Examination of in-
fected cultures by electron microscopy confirmed that both
FIG. 4. In nontreated cultures and in those treated with lower doses of inhibitors, the development of the parasite results in the production of
numerous spores. The electron-dense stages are sporoblasts maturing into spores. Abbreviations: HN, host cell nucleus; Me, two meronts applied
to the PV membrane outlined with glycogen granules (arrowheads). Scale bar, 2 m.
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compounds caused a gradual resorption of the infection. In
cultures treated with the lower doses, most cells were infected.
Normally fusiform, these cells became rounded due to the
presence of a large PV (Fig. 4). Two or three PVs could be
seen in some cells. All developmental stages of the parasite
were present in these vacuoles, which contained up to 20
spores. At a concentration of 0.5 M, flat cells containing small
PVs with a concomitant decrease in the number of mature
spores were observed. In some cells, PVs contained meronts as
well as a small number of sporoblasts and spores that were
larger (3 to 4 m) than those produced in the absence of
inhibitors. Additionally, some alterations were observed in the
polar tube, a major component of the spore extrusion appara-
tus. Eight to nine coils of the polar tube were numbered in
large sporoblasts and spores, instead of the five to six charac-
teristic of the species (data not shown). Most interesting was
the occurrence of two nuclei in sporoblasts and in spores (Fig.
5A and B and 6A). In most sections, these nuclei were abutted,
thus displaying diplokaryotic arrangement. Used at the same
concentration (0.5 M), 7-deoxynarciclasine exerted a similar
effect, although to a lesser extent.
At the highest dose (1 M), sporogonic stages, i.e., sporonts,
sporoblasts, and spores, were less frequent or even absent in
PVs that, however, still contained meronts. Only one large
FIG. 5. Sporoblasts and spores generated in cultures treated with 0.5 M pancratistatin contain two nuclei (N). (A) Two binucleate sporoblasts.
(B) Only one polar tube (arrows) can be seen in this section of a binucleate sporoblast. The nuclei are assembled into a diplokaryon. (C) The
mononucleate sporoblast of E. intestinalis in the absence of treatment with pancratistatin or 7-deoxynarciclasine. Scale bars, 0.5 m.
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mononucleate meront reaching up to 10 m in diameter was
observed in most cells treated with 1 M pancratistatin (Fig.
6B). The occurrence of polar vesicles and intranuclear micro-
tubules indicated that these meronts were engaged in the pro-
cess of division at the time of sample fixation.
Deeply altered parasites embedded in an electron-dense ma-
terial were also frequently observed in cells treated with any
dose of the compounds (Fig. 7). No alterations were observed
in RK13 cells. However, cells with an electron-dense nucleus
were frequently seen in cultures (infected or not) treated with
7-deoxynarciclasine. DMSO-treated control cultures did not
show any sign of morphological alteration, either in the host
cell or in parasites.
DISCUSSION
Pancratistatin, 7-deoxynarciclasine, and parasite develop-
ment. We have tested a small collection of compounds con-
taining a large proportion of kinase inhibitors, especially CDK
inhibitors such as purines, paullones, and indirubins. Most
compounds proved inefficient in specifically inhibiting para-
sites while preserving the host cells. Two out of 526 compounds
were found to be selective for the parasites, and, interestingly,
they appeared to be closely related in their structure (Fig. 2).
Pancratistatin and 7-deoxynarciclasin have been originally
identified as antitumor agents extracted from P. littorale, a
Hawaiian member of the family Amaryllidaceae, and related
species (17, 18, 19). As many pancratistatin derivatives have
been synthesized, we are now testing this family of compounds,
with the purpose of identifying a pancratistatin analogue with
improved selectivity for microsporidia.
A significant reduction of the microsporidian infection was
obtained when cultures were treated with two compounds
tested in this study. Both IFA and electron microscopy suggest
that the molecules blocked the intracellular development
FIG. 6. Two sporogonic stages in a culture treated with 0.5 M pancratistatin. (A) An electron dense diplokaryotic sporoblast is transforming
into a mature spore. The median constriction (arrow) of the thick walled spore is another indication that this stage originates from a sporont that
did not complete its division. (B) A large mononucleate meront in a cell treated with 1 M pancratistatin. The vesicles (arrows) characteristic of
microsporidia mitotic poles indicate that the nucleus is engaged into the division process. Scale bars, 1 m.
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rather than the entry of the parasites into the host cell. Indeed,
transmission electron microscope examination of apparently
uninfected cells revealed the persistence of merogonic stages
which were not detected by the MAb directed against a protein
specific to the sporogonic stages. Furthermore, most spores
generated in the PV in the presence of inhibitor lack the typical
thick wall, suggesting that they were not mature enough to
spread the infection through the culture. Sporogony itself was
totally inhibited at the higher concentration of 1 M while only
a few merogonic stages were usually observed. These meronts
were larger than those observed in cultures not treated or
treated with lower doses of inhibitors. That these cells were
engaged in a division process was indicated by the occurrence
of vesicular structures characteristic of microsporidian mitotic
poles at the surface of the nucleus (Fig. 6B). However, the
large size of the nucleus and the absence of mitotic spindle
suggested that the production of these giant meronts resulted
from some alteration of the mitosis. A longer cytokinesis due
to an alteration in the timing of cell division may cause the
uncoupling of cell division and differentiation, as was demon-
strated in trypanosomatid parasites (23). Thus, a major effect
of the molecules consisted of abnormalities in the development
of the parasite.
It is very likely that the decrease in the number of spores and
their abnormally large size result from a reduction in the mi-
totic activity of sporonts and sporoblasts. The decrease in pro-
duction of developmental stages and their concomitant en-
largement were observed in the microsporidian E. cuniculi
treated with albendazole, an inhibitor of tubulin polymeriza-
tion. This effect was interpreted as a result from the alteration
of the mitotic activity of the parasite (5, 21). Some effects
similar to those observed in microsporidia treated with pan-
cratistatin were caused by the protein kinase inhibitor stauro-
sporine (which has a low specificity and inhibits kinases of
several families) in Leishmania promastigotes. These stages
were swollen and did not divide in culture, although they were,
however, capable of differentiating into amastigotes (2). Stau-
rosporine and other kinase inhibitors were shown to inhibit the
invasion and intraerythrocytic development of Plasmodium fal-
ciparum (8).
Binucleate sporoblasts and spores induced by pancratista-
tin and 7-deoxynarciclasine. These molecules appear to block
cell division in microsporidia in a dose-dependent manner.
Morphological changes occurred gradually with the concentra-
tion. Binucleate sporoblasts and spores were seen in culture
treated with 0.5 M pancratistatin. Although less frequent,
they were also observed in those treated with the same dose of
7-deoxynarciclasine. Apparently, the inhibitor caused a block
in the cytodieresis of the sporonts, thus generating these binu-
cleate sporoblasts which, however, were still able to differen-
tiate into mature spores (Fig. 5A and B and 6A). Sporogony
itself was totally inhibited at the highest dose (1 M).
Surprisingly, the nuclei present in binucleate sporoblasts and
spores display the diplokaryon arrangement observed in many
microsporidian species (7). No diplokaryotic phase occurs in
the life cycle of Encephalitozoonidae, but the alteration in-
duced in E. intestinalis by pancratistatin, and to a lower degree
by 7-deoxynarciclasine, mimics the development of other mi-
crosporidia, including polymorphic species generating mono-
karyotic and diplokaryotic spores alternately (14). A variety of
environmental factors possibly associated with sexual processes
are involved in spore polymorphism. However, the underlying
molecular mechanisms have not yet been investigated.
The molecular targets of the antitumor agents pancratistatin
and 7-deoxynarciclasine have not yet been identified in human
cells. The electron-dense contents of the nucleus which we
frequently observed in 7-deoxynarclasine-treated RK13 cells
suggest an arrest of the division process occurring after
prophasic condensation of chromatin. Thus, these cells were
apparently dividing but some block in mitosis occurred before
metaphasis. More work is needed to identify the target of the
inhibitors discussed here. A possible approach would be the
purification of putative targets by affinity chromatography on
immobilized inhibitors (12).
FIG. 7. Alterations of the parasite in cells treated with the inhibitors. Degenerative stages (arrowheads) are scattered in the host cell cytoplasm.
Scale bar, 0.5 m.
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The recent classification of microsporidia with the fungi (25)
suggests that the different phases of their cell cycle may be
controlled by a single CDK, as is the case in yeasts (13).
However, some of the results reported here tend to indicate
that a combination of different factors and effectors ensures
the regulation of the life cycle in microsporidia. Thus, the
information provided by this study is of dual interest: on one
hand it points to new potential therapeutic tools which cer-
tainly deserve further characterization (notably, in terms of
their effect during infection of animals), and on the other hand
these molecules represent promising tools for investigating the
diversity of the microsporidian life cycles.
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